We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Early Screening System Detects Diabetic Retinopathy

By HospiMedica International staff writers
Posted on 12 May 2014
Print article
A novel end-to-end retinal screening solution quickly identifies and diagnoses patients with diabetic retinal disease.

The iConnect Retinal Screening solution enables providers to efficiently capture retinal images through an automated camera, reducing the need for staff to receive specialty training. Images are transferred via the cloud to the Merge Eye Care PACS reading center, an interoperable, subscription-based service where trained technicians and pathologists bear the responsibility of identifying, diagnosing, and delivering results. The results are then transmitted via the iConnect Network to the provider's electronic health record (EHR) system to allow for timely, customized care plans.

The solution thus streamlines operational workflow, reduces financial costs, and enables of the improvement of clinical care quality by leveraging the iConnect Cloud Archive infrastructure. The first phase of the solution will enable automated, early screening detection of diabetic retinopathy, an increasingly common complication of diabetes and one of the leading causes of visual impairment and blindness among working-aged adults. The iConnect Retinal Screening solution, Eye Care PACS, and iConnect Network are services of Merge Healthcare (Chicago, IL, USA).

“Diabetes affects more than 347 million people globally, and it's estimated that one out of every five US healthcare dollars is spent on this disease,” said Steven Tolle, chief strategy officer at Merge Healthcare. “By creating a solution that addresses both patient and provider knowledge gaps, we're helping providers more easily diagnose and treat not only diabetes, but retinal disease as a whole. Patients, in turn, are empowered with faster treatment plans which can reduce the risk of negative side effects.”

“By leveraging our existing cloud technology, Merge customers will be able to enhance care for the large number of diabetic patients in our nation,” said Justin Dearborn, CEO of Merge Healthcare. “Our deep expertise with other specialty screenings, such as mammography, cervical and cardiology, positions us well to help in the eye care market. This new, end-to-end solution will be a win-win for patients and providers, enabling a detrimental disease to be diagnosed and treated earlier having the additional benefit of reducing short- and long-term healthcare costs.”

The iConnect Network allows hospitals, providers, and imaging centers to exchange imaging information electronically with community physicians that are connected to Health Information Exchanges (HIEs) or electronic health records (EHR) networks, such as the Surescripts (Arlington, VA, USA) Clinical Network Services (CNS).

Related Links:

Merge Healthcare
Surescripts


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Electric Bariatric Patient Lifter
SVBL 205

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more